| Purpose: To conduct a small clinical trial of Xuefu Zhuyu Oral Liquid in treating primary stagnation and congestive syndrome dysmenorrhea is to observe the effect of Xuefu Zhuyu Oral Liquid on dysmenorrhea in patients with stagnation and congestion syndrome.Scores,self-reported anxiety scale and Pittsburgh sleep quality index.Material and method: We selected 100 patients with Qi stagnation and congestive syndrome primary dysmenorrhea,and randomly divided 50 patients from each group into two groups,a study group and a control group.The test group took Xuefu Zhuyu Oral Liquid 3times a day,2 bottles/time,and took it on an empty stomach for 2 weeks before menstruation;the control group took a placebo control,and the adminsttion method and measurment were in agreement with the expermental group.Observe changes in the TCM syndre score,between the SAS score,and in the PSQI score of patient treatment with the two groups.Results:1.Prior to treatment,two groups of patnts had no statistical difference in age,menstual cycle,disease,VAS score,SAS score and PSQI total score(P> 0.05).They were equal.2.Intragroup comparison before and after treatment: After treatment,VAS score,SAS score,and PSQI score of the experal group were signtly lower than treatment.After sanalysis,P<0.05,which is statistically significant.3.Comparison of the two groups after treatment: After treatment,the VAS score,SAS score,and PSQI total score of the group signifitly lower than those of the control group.After statistical analysis,P <0.05,which was statistically significant.Conclusion:Oral administration of Xuefu Zhuyu Oral Liquid can relieve menstrual abdominal pain in patients with qi stagnation and blood stasis syndrome,reduce their menstrual anxiety,and improve their sleep quality.It is useful for treating primary dysmenorrhea with qi stagnation and blood stasis syndrome.good effect.In addition,Xuefu Zhuyu Oral Liquid is easy to take,convenient to carry,can be stored for a long time,saves time and effort,and is worthy of clinical use and promotion. |